Bulletin
Investor Alert

Biogen Inc.

NAS: BIIB

GO
/marketstate/country/us

After Hours

/zigman2/quotes/201531540/composite

$

289.01

Change

-1.07 -0.37%

Volume

Volume 27,019

Jan 27, 2023, 7:28 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/201531540/composite

Previous close

$ 291.92

$ 290.08

Change

-1.84 -0.63%

Day low

Day high

$289.94

$295.90

Open
Open: 292.36

52 week low

52 week high

$187.16

$311.88

Open

Market cap

$41.77B

Average volume

1.21M

P/E ratio

14.78

Rev. per Employee

$1.00M

EPS

19.63

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/biib

MarketWatch News on BIIB

  1. Eating these simple foods may slow Alzheimer’s by a third

    12:07 p.m. Jan. 21, 2023

    - Brett Arends

  2. The FDA Rejected Lilly's Alzheimer's Drug. Why It's Only a Setback.

    11:21 a.m. Jan. 20, 2023

    - Josh Nathan-Kazis

  3. The Year's Biggest Healthcare Conference Starts Today

    8:44 a.m. Jan. 9, 2023

    - Josh Nathan-Kazis

  4. The FDA Has Approved Eisai and Biogen's New Alzheimer's Therapy

    5:55 p.m. Jan. 6, 2023

    - Josh Nathan-Kazis

  5. Eisai U.S.–listed stock up 10%

    2:16 p.m. Jan. 6, 2023

    - Ciara Linnane

  6. FDA grants accelerated approval to Eisai for Alzheimer’s treatment Leqembi

    2:12 p.m. Jan. 6, 2023

    - Ciara Linnane

  7. Biogen stock halted for news pending

    2:03 p.m. Jan. 6, 2023

    - Ciara Linnane

  8. Biogen stock halted for news pending

    2:03 p.m. Jan. 6, 2023

    - Ciara Linnane

  9. The FDA's Next Call on an Alzheimer's Drug Is Due This Week

    12:37 p.m. Jan. 3, 2023

    - Josh Nathan-Kazis

  10. Novavax, Micron, Biogen, and More Stock Market Movers

    4:42 p.m. Dec. 30, 2022

    - Joe Woelfel

  11. New Alzheimer's Drug Could Cost $20,000 a Year: Group

    4:59 a.m. Dec. 23, 2022

    - Josh Nathan-Kazis

  12. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/biib

Other News on BIIB

  1. A Better Future for ALS Patients

    2:59 p.m. Today

    - Andy Kessler

  2. Top 5 4th Quarter Trades of Cardinal Capital Management

    10:00 a.m. Jan. 23, 2023

    - GuruFocus.com

  3. FDA Chief Denies Wrongdoing in Biogen Alzheimer’s Drug Approval

    4:48 p.m. Jan. 10, 2023

    - Liz Essley Whyte

  4. Primecap Odyssey Funds' 2022 Annual Shareholder Letter

    3:05 p.m. Dec. 16, 2022

    - GuruFocus.com

  5. Among the Best-Managed Companies of 2022, Some Warning Signs

    9:08 a.m. Dec. 11, 2022

    - Chris Kornelis

  6. BIIB vs. TECH: Which Stock Is the Better Value Option?

    11:40 a.m. Dec. 9, 2022

    - Zacks.com

  7. Esperion (ESPR) Reports Positive Data From CLEAR Study

    10:04 a.m. Dec. 8, 2022

    - Zacks.com

  8. Loading more headlines...
/news/pressrelease/company/us/biib

Press Releases on BIIB

  1. When the Price of Biogen Inc. Common Stock BIIB Talks, People Listen

    7:47 p.m. Jan. 26, 2023

    - Stock Traders Daily

  2. Biogen Inc. Common Stock BIIB Investment Analysis and Advice

    4:49 a.m. Jan. 17, 2023

    - Stock Traders Daily

  3. Biogen Inc. Common Stock BIIB Pivots Trading Plans and Risk Controls

    1:24 p.m. Jan. 7, 2023

    - Stock Traders Daily

  4. Biogen Inc. Common Stock BIIB Trading Advice

    11:07 p.m. Dec. 28, 2022

    - Stock Traders Daily

  5. EISAI INITIATES BLA SUBMISSION OF DATA FOR LECANEMAB IN CHINA

    6:45 p.m. Dec. 22, 2022

    - PR Newswire - PRF

  6. Biogen Inc. Common Stock (BIIB) Trading Report

    8:02 a.m. Dec. 19, 2022

    - Stock Traders Daily

  7. Biogen Inc. Common Stock (BIIB) Trading Report

    4:53 p.m. Dec. 9, 2022

    - Stock Traders Daily

  8. Loading more headlines...

Rates »

Link to MarketWatch's Slice.